GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Prenetics Global Ltd (NAS:PRE) » Definitions » Operating Margin %

Prenetics Global (Prenetics Global) Operating Margin % : -303.56% (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Prenetics Global Operating Margin %?

Operating Margin % is calculated as Operating Income divided by its Revenue. Prenetics Global's Operating Income for the three months ended in Sep. 2023 was $-14.77 Mil. Prenetics Global's Revenue for the three months ended in Sep. 2023 was $4.87 Mil. Therefore, Prenetics Global's Operating Margin % for the quarter that ended in Sep. 2023 was -303.56%.

The historical rank and industry rank for Prenetics Global's Operating Margin % or its related term are showing as below:

PRE' s Operating Margin % Range Over the Past 10 Years
Min: -197.44   Med: -1.14   Max: 2.61
Current: -157.56


PRE's Operating Margin % is ranked worse than
80% of 225 companies
in the Medical Diagnostics & Research industry
Industry Median: -5.06 vs PRE: -157.56

Prenetics Global's 5-Year Average Operating Margin % Growth Rate was 0.00% per year.

Prenetics Global's Operating Income for the three months ended in Sep. 2023 was $-14.77 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Sep. 2023 was $-53.08 Mil.


Prenetics Global Operating Margin % Historical Data

The historical data trend for Prenetics Global's Operating Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Prenetics Global Operating Margin % Chart

Prenetics Global Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Operating Margin %
-197.44 1.48 -3.75 2.61 -220.79

Prenetics Global Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Operating Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 23.89 -74.96 -238.27 -303.56 -211.35

Competitive Comparison of Prenetics Global's Operating Margin %

For the Diagnostics & Research subindustry, Prenetics Global's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Prenetics Global's Operating Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Prenetics Global's Operating Margin % distribution charts can be found below:

* The bar in red indicates where Prenetics Global's Operating Margin % falls into.



Prenetics Global Operating Margin % Calculation

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Prenetics Global's Operating Margin % for the fiscal year that ended in Dec. 2022 is calculated as

Operating Margin %=Operating Income (A: Dec. 2022 ) / Revenue (A: Dec. 2022 )
=7.206 / 275.761
=2.61 %

Prenetics Global's Operating Margin % for the quarter that ended in Sep. 2023 is calculated as

Operating Margin %=Operating Income (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=-14.771 / 4.866
=-303.56 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Prenetics Global  (NAS:PRE) Operating Margin % Explanation

Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.


Be Aware

Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia’s Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


Prenetics Global Operating Margin % Related Terms

Thank you for viewing the detailed overview of Prenetics Global's Operating Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Prenetics Global (Prenetics Global) Business Description

Traded in Other Exchanges
N/A
Address
Unit 701-706, K11 Atelier King’s Road, 728 King’s Road, Quarry Bay, Hong Kong, HKG
Prenetics Global Ltd is a diagnostic and genetic testing company. It is a genomics and precision oncology company that has devised a method to integrate early detection for cancer, targeted therapy and direct-to-consumer genetic testing services into one comprehensive platform. It operates in two segments. The prevention segment includes the design & sale of genetics testing (including update services) & stool-based DNA tests for early colorectal cancer screening. The diagnostic segment includes the sale of COVID-19 testing services & products and precision oncology services. The majority of revenue is from the diagnostics segment. Geographically, it operates in Hong Kong and the United Kingdom, out of which the majority is from Hong Kong.